1 Poliomyelitis Vaccine Market Overview 1.1 Product Overview and Scope of Poliomyelitis Vaccine 1.2 Poliomyelitis Vaccine Segment by Type 1.2.1 Global Poliomyelitis Vaccine Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Poliomyelitis Vaccine Ⅰ 1.2.3 Poliomyelitis Vaccine Ⅱ 1.2.4 Poliomyelitis Vaccine Ⅲ 1.2.5 Oral Poliomyelitis Vaccine 1.3 Poliomyelitis Vaccine Segment by Application 1.3.1 Poliomyelitis Vaccine Sales Comparison by Application: 2020 VS 2026 1.3.2 VAPP 1.3.3 VDPV 1.4 Global Poliomyelitis Vaccine Market Size Estimates and Forecasts 1.4.1 Global Poliomyelitis Vaccine Revenue 2015-2026 1.4.2 Global Poliomyelitis Vaccine Sales 2015-2026 1.4.3 Poliomyelitis Vaccine Market Size by Region: 2020 Versus 2026 1.5 Poliomyelitis Vaccine Industry 1.6 Poliomyelitis Vaccine Market Trends 2 Global Poliomyelitis Vaccine Market Competition by Manufacturers 2.1 Global Poliomyelitis Vaccine Sales Market Share by Manufacturers (2015-2020) 2.2 Global Poliomyelitis Vaccine Revenue Share by Manufacturers (2015-2020) 2.3 Global Poliomyelitis Vaccine Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Poliomyelitis Vaccine Manufacturing Sites, Area Served, Product Type 2.5 Poliomyelitis Vaccine Market Competitive Situation and Trends 2.5.1 Poliomyelitis Vaccine Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Poliomyelitis Vaccine Players (Opinion Leaders) 3 Poliomyelitis Vaccine Retrospective Market Scenario by Region 3.1 Global Poliomyelitis Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Poliomyelitis Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Poliomyelitis Vaccine Market Facts & Figures by Country 3.3.1 North America Poliomyelitis Vaccine Sales by Country 3.3.2 North America Poliomyelitis Vaccine Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Poliomyelitis Vaccine Market Facts & Figures by Country 3.4.1 Europe Poliomyelitis Vaccine Sales by Country 3.4.2 Europe Poliomyelitis Vaccine Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Poliomyelitis Vaccine Market Facts & Figures by Region 3.5.1 Asia Pacific Poliomyelitis Vaccine Sales by Region 3.5.2 Asia Pacific Poliomyelitis Vaccine Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Poliomyelitis Vaccine Market Facts & Figures by Country 3.6.1 Latin America Poliomyelitis Vaccine Sales by Country 3.6.2 Latin America Poliomyelitis Vaccine Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Poliomyelitis Vaccine Market Facts & Figures by Country 3.7.1 Middle East and Africa Poliomyelitis Vaccine Sales by Country 3.7.2 Middle East and Africa Poliomyelitis Vaccine Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Poliomyelitis Vaccine Historic Market Analysis by Type 4.1 Global Poliomyelitis Vaccine Sales Market Share by Type (2015-2020) 4.2 Global Poliomyelitis Vaccine Revenue Market Share by Type (2015-2020) 4.3 Global Poliomyelitis Vaccine Price Market Share by Type (2015-2020) 4.4 Global Poliomyelitis Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Poliomyelitis Vaccine Historic Market Analysis by Application 5.1 Global Poliomyelitis Vaccine Sales Market Share by Application (2015-2020) 5.2 Global Poliomyelitis Vaccine Revenue Market Share by Application (2015-2020) 5.3 Global Poliomyelitis Vaccine Price by Application (2015-2020) 6 Company Profiles and Key Figures in Poliomyelitis Vaccine Business 6.1 GSK 6.1.1 Corporation Information 6.1.2 GSK Description, Business Overview and Total Revenue 6.1.3 GSK Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.1.4 GSK Products Offered 6.1.5 GSK Recent Development 6.2 Sanofi-Pasteur 6.2.1 Sanofi-Pasteur Corporation Information 6.2.2 Sanofi-Pasteur Description, Business Overview and Total Revenue 6.2.3 Sanofi-Pasteur Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Sanofi-Pasteur Products Offered 6.2.5 Sanofi-Pasteur Recent Development 6.3 Merck 6.3.1 Merck Corporation Information 6.3.2 Merck Description, Business Overview and Total Revenue 6.3.3 Merck Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Merck Products Offered 6.3.5 Merck Recent Development 6.4 Crucell 6.4.1 Crucell Corporation Information 6.4.2 Crucell Description, Business Overview and Total Revenue 6.4.3 Crucell Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Crucell Products Offered 6.4.5 Crucell Recent Development 6.5 China National Biotech Group 6.5.1 China National Biotech Group Corporation Information 6.5.2 China National Biotech Group Description, Business Overview and Total Revenue 6.5.3 China National Biotech Group Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.5.4 China National Biotech Group Products Offered 6.5.5 China National Biotech Group Recent Development 6.6 Eli Lilly 6.6.1 Eli Lilly Corporation Information 6.6.2 Eli Lilly Description, Business Overview and Total Revenue 6.6.3 Eli Lilly Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Eli Lilly Products Offered 6.6.5 Eli Lilly Recent Development 7 Poliomyelitis Vaccine Manufacturing Cost Analysis 7.1 Poliomyelitis Vaccine Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Poliomyelitis Vaccine 7.4 Poliomyelitis Vaccine Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Poliomyelitis Vaccine Distributors List 8.3 Poliomyelitis Vaccine Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Poliomyelitis Vaccine Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Poliomyelitis Vaccine by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Poliomyelitis Vaccine by Type (2021-2026) 10.2 Poliomyelitis Vaccine Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Poliomyelitis Vaccine by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Poliomyelitis Vaccine by Application (2021-2026) 10.3 Poliomyelitis Vaccine Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Poliomyelitis Vaccine by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Poliomyelitis Vaccine by Region (2021-2026) 10.4 North America Poliomyelitis Vaccine Estimates and Projections (2021-2026) 10.5 Europe Poliomyelitis Vaccine Estimates and Projections (2021-2026) 10.6 Asia Pacific Poliomyelitis Vaccine Estimates and Projections (2021-2026) 10.7 Latin America Poliomyelitis Vaccine Estimates and Projections (2021-2026) 10.8 Middle East and Africa Poliomyelitis Vaccine Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Poliomyelitis Vaccine Sales (K Units) Growth Rate Comparison by Type (2015-2026) Table 2. Global Poliomyelitis Vaccine Sales (K Units) Comparison by Application: 2020 VS 2026 Table 3. Global Poliomyelitis Vaccine Market Size by Type (K Units) (US$ Million) (2020 VS 2026) Table 4. Global Key Poliomyelitis Vaccine Manufacturers Covered in This Study Table 5. Global Poliomyelitis Vaccine Sales (K Units) by Manufacturers (2015-2020) Table 6. Global Poliomyelitis Vaccine Sales Share by Manufacturers (2015-2020) Table 7. Global Poliomyelitis Vaccine Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Poliomyelitis Vaccine Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Poliomyelitis Vaccine Average Price (USD/Unit) of Key Manufacturers (2015-2020) Table 10. Manufacturers Poliomyelitis Vaccine Sales Sites and Area Served Table 11. Manufacturers Poliomyelitis Vaccine Product Types Table 12. Global Poliomyelitis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Poliomyelitis Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Poliomyelitis Vaccine as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Poliomyelitis Vaccine Players Table 16. Global Poliomyelitis Vaccine Sales (K Units) by Region (2015-2020) Table 17. Global Poliomyelitis Vaccine Sales Market Share by Region (2015-2020) Table 18. Global Poliomyelitis Vaccine Revenue (Million US$) by Region (2015-2020) Table 19. Global Poliomyelitis Vaccine Revenue Market Share by Region (2015-2020) Table 20. North America Poliomyelitis Vaccine Sales by Country (2015-2020) (K Units) Table 21. North America Poliomyelitis Vaccine Sales Market Share by Country (2015-2020) Table 22. North America Poliomyelitis Vaccine Revenue by Country (2015-2020) (US$ Million) Table 23. North America Poliomyelitis Vaccine Revenue Market Share by Country (2015-2020) Table 24. Europe Poliomyelitis Vaccine Sales by Country (2015-2020) (K Units) Table 25. Europe Poliomyelitis Vaccine Sales Market Share by Country (2015-2020) Table 26. Europe Poliomyelitis Vaccine Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Poliomyelitis Vaccine Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Poliomyelitis Vaccine Sales by Region (2015-2020) (K Units) Table 29. Asia Pacific Poliomyelitis Vaccine Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Poliomyelitis Vaccine Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Poliomyelitis Vaccine Revenue Market Share by Region (2015-2020) Table 32. Latin America Poliomyelitis Vaccine Sales by Country (2015-2020) (K Units) Table 33. Latin America Poliomyelitis Vaccine Sales Market Share by Country (2015-2020) Table 34. Latin America Poliomyelitis Vaccine Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Poliomyelitis Vaccine Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Poliomyelitis Vaccine Sales by Country (2015-2020) (K Units) Table 37. Middle East and Africa Poliomyelitis Vaccine Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Poliomyelitis Vaccine Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Poliomyelitis Vaccine Revenue Market Share by Country (2015-2020) Table 40. Global Poliomyelitis Vaccine Sales (K Units) by Type (2015-2020) Table 41. Global Poliomyelitis Vaccine Sales Share by Type (2015-2020) Table 42. Global Poliomyelitis Vaccine Revenue (Million US$) by Type (2015-2020) Table 43. Global Poliomyelitis Vaccine Revenue Share by Type (2015-2020) Table 44. Global Poliomyelitis Vaccine Price (USD/Unit) by Type (2015-2020) Table 45. Global Poliomyelitis Vaccine Sales (K Units) by Application (2015-2020) Table 46. Global Poliomyelitis Vaccine Sales Market Share by Application (2015-2020) Table 47. Global Poliomyelitis Vaccine Sales Growth Rate by Application (2015-2020) Table 48. GSK Poliomyelitis Vaccine Corporation Information Table 49. GSK Description and Business Overview Table 50. GSK Poliomyelitis Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 51. GSK Main Product Table 52. GSK Recent Development Table 53. Sanofi-Pasteur Poliomyelitis Vaccine Corporation Information Table 54. Sanofi-Pasteur Corporation Information Table 55. Sanofi-Pasteur Poliomyelitis Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 56. Sanofi-Pasteur Main Product Table 57. Sanofi-Pasteur Recent Development Table 58. Merck Poliomyelitis Vaccine Corporation Information Table 59. Merck Corporation Information Table 60. Merck Poliomyelitis Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 61. Merck Main Product Table 62. Merck Recent Development Table 63. Crucell Poliomyelitis Vaccine Corporation Information Table 64. Crucell Corporation Information Table 65. Crucell Poliomyelitis Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 66. Crucell Main Product Table 67. Crucell Recent Development Table 68. China National Biotech Group Poliomyelitis Vaccine Corporation Information Table 69. China National Biotech Group Corporation Information Table 70. China National Biotech Group Poliomyelitis Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 71. China National Biotech Group Main Product Table 72. China National Biotech Group Recent Development Table 73. Eli Lilly Poliomyelitis Vaccine Corporation Information Table 74. Eli Lilly Corporation Information Table 75. Eli Lilly Poliomyelitis Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 76. Eli Lilly Main Product Table 77. Eli Lilly Recent Development Table 78. Sales Base and Market Concentration Rate of Raw Material Table 79. Key Suppliers of Raw Materials Table 80. Poliomyelitis Vaccine Distributors List Table 81. Poliomyelitis Vaccine Customers List Table 82. Market Key Trends Table 83. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 84. Key Challenges Table 85. Global Poliomyelitis Vaccine Sales (K Units) Forecast by Type (2021-2026) Table 86. Global Poliomyelitis Vaccine Sales Market Share Forecast by Type (2021-2026) Table 87. Global Poliomyelitis Vaccine Revenue (Million US$) Forecast by Type (2021-2026) Table 88. Global Poliomyelitis Vaccine Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 89. Global Poliomyelitis Vaccine Sales (K Units) Forecast by Application (2021-2026) Table 90. Global Poliomyelitis Vaccine Revenue (Million US$) Forecast by Application (2021-2026) Table 91. Global Poliomyelitis Vaccine Sales (K Units) Forecast by Region (2021-2026) Table 92. Global Poliomyelitis Vaccine Sales Market Share Forecast by Region (2021-2026) Table 93. Global Poliomyelitis Vaccine Revenue Forecast by Region (2021-2026) (US$ Million) Table 94. Global Poliomyelitis Vaccine Revenue Market Share Forecast by Region (2021-2026) Table 95. Research Programs/Design for This Report Table 96. Key Data Information from Secondary Sources Table 97. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Poliomyelitis Vaccine Figure 2. Global Poliomyelitis Vaccine Sales Market Share by Type: 2020 VS 2026 Figure 3. Poliomyelitis Vaccine Ⅰ Product Picture Figure 4. Poliomyelitis Vaccine Ⅱ Product Picture Figure 5. Poliomyelitis Vaccine Ⅲ Product Picture Figure 6. Oral Poliomyelitis Vaccine Product Picture Figure 7. Global Poliomyelitis Vaccine Consumption Market Share by Application: 2020 VS 2026 Figure 8. VAPP Figure 9. VDPV Figure 10. Global Poliomyelitis Vaccine Market Size 2015-2026 (US$ Million) Figure 11. Global Poliomyelitis Vaccine Sales Capacity (K Units) (2015-2026) Figure 12. Global Poliomyelitis Vaccine Market Size Market Share by Region: 2020 Versus 2026 Figure 13. Poliomyelitis Vaccine Sales Share by Manufacturers in 2020 Figure 14. Global Poliomyelitis Vaccine Revenue Share by Manufacturers in 2019 Figure 15. The Global 5 and 10 Largest Players: Market Share by Poliomyelitis Vaccine Revenue in 2019 Figure 16. Poliomyelitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 17. Global Poliomyelitis Vaccine Sales Market Share by Region (2015-2020) Figure 18. Global Poliomyelitis Vaccine Sales Market Share by Region in 2019 Figure 19. Global Poliomyelitis Vaccine Revenue Market Share by Region (2015-2020) Figure 20. Global Poliomyelitis Vaccine Revenue Market Share by Region in 2019 Figure 21. North America Poliomyelitis Vaccine Sales Market Share by Country in 2019 Figure 22. North America Poliomyelitis Vaccine Revenue Market Share by Country in 2019 Figure 23. U.S. Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 24. U.S. Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Canada Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 26. Canada Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 27. Europe Poliomyelitis Vaccine Sales Market Share by Country in 2019 Figure 28. Europe Poliomyelitis Vaccine Revenue Market Share by Country in 2019 Figure 29. Germany Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 30. Germany Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. France Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 32. France Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. U.K. Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 34. U.K. Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Italy Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 36. Italy Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Russia Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 38. Russia Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Asia Pacific Poliomyelitis Vaccine Sales Market Share by Region in 2019 Figure 40. Asia Pacific Poliomyelitis Vaccine Revenue Market Share by Region in 2019 Figure 41. China Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 42. China Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. Japan Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 44. Japan Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. South Korea Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 46. South Korea Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. India Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 48. India Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Australia Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 50. Australia Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Taiwan Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 52. Taiwan Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Indonesia Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 54. Indonesia Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Thailand Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 56. Thailand Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Malaysia Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 58. Malaysia Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Philippines Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 60. Philippines Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Vietnam Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 62. Vietnam Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Latin America Poliomyelitis Vaccine Sales Market Share by Country in 2019 Figure 64. Latin America Poliomyelitis Vaccine Revenue Market Share by Country in 2019 Figure 65. Mexico Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 66. Mexico Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Brazil Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 68. Brazil Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Argentina Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 70. Argentina Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Middle East and Africa Poliomyelitis Vaccine Sales Market Share by Country in 2019 Figure 72. Middle East and Africa Poliomyelitis Vaccine Revenue Market Share by Country in 2019 Figure 73. Turkey Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 74. Turkey Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Saudi Arabia Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 76. Saudi Arabia Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. U.A.E Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units) Figure 78. U.A.E Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Sales Market Share of Poliomyelitis Vaccine by Type (2015-2020) Figure 80. Sales Market Share of Poliomyelitis Vaccine by Type in 2019 Figure 81. Revenue Share of Poliomyelitis Vaccine by Type (2015-2020) Figure 82. Revenue Market Share of Poliomyelitis Vaccine by Type in 2019 Figure 83. Global Poliomyelitis Vaccine Sales Growth by Type (2015-2020) (K Units) Figure 84. Global Poliomyelitis Vaccine Sales Market Share by Application (2015-2020) Figure 85. Global Poliomyelitis Vaccine Sales Market Share by Application in 2019 Figure 86. Global Revenue Share of Poliomyelitis Vaccine by Application (2015-2020) Figure 87. Global Revenue Share of Poliomyelitis Vaccine by Application in 2020 Figure 88. GSK Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. Sanofi-Pasteur Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Crucell Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. China National Biotech Group Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Price Trend of Key Raw Materials Figure 95. Manufacturing Cost Structure of Poliomyelitis Vaccine Figure 96. Manufacturing Process Analysis of Poliomyelitis Vaccine Figure 97. Poliomyelitis Vaccine Industrial Chain Analysis Figure 98. Channels of Distribution Figure 99. Distributors Profiles Figure 100. Porter's Five Forces Analysis Figure 101. North America Poliomyelitis Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 102. North America Poliomyelitis Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 103. Europe Poliomyelitis Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 104. Europe Poliomyelitis Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 105. Latin America Poliomyelitis Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 106. Latin America Poliomyelitis Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 107. Middle East and Africa Poliomyelitis Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 108. Middle East and Africa Poliomyelitis Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 109. Asia Pacific Poliomyelitis Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 110. Asia Pacific Poliomyelitis Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 111. Bottom-up and Top-down Approaches for This Report Figure 112. Data Triangulation Figure 113. Key Executives Interviewed

GSK Sanofi-Pasteur Merck Crucell China National Biotech Group Eli Lilly